Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovative siroLimus seLf Expanding drUg-eluting Stent for the treatMent of perIpheral Disease: Evaluation of Safety aNd efficAcy. The ILLUMINA Study. (ILLUMINA)

NCT03510676 is registered in ClinicalTrials.gov with CID - Carbostent & Implantable Devices as lead sponsor.

NCT NCT03510676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03510676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovative siroLimus seLf Expanding drUg-eluting Stent for the treatMent of perIpheral Disease: Evaluation of Safety aNd efficAcy. The ILLUMINA Study. (ILLUMINA)
Lead sponsor
CID - Carbostent & Implantable Devices
Phase
Not applicable
Overall status
Completed
Start date
January 26, 2016
Completion date
March 7, 2019
Enrollment
100 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease